Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression

Free App Helps Patients as They Manage their Condition through their
iPhone with Easy-to-Use Features

NEW YORK–(BUSINESS WIRE)–Today, Pfizer Inc announced it has launched a new app, Moodivator, to
help motivate and encourage the millions of adults who experience
depression. Depression is one of the most common mental health disorders
in the United States, as an estimated one in 15 adults (6.7%) experience
at least one major depressive episode in any given year.

Living with depression can feel isolating, overwhelming and impact all
aspects of a person’s life. An increasing number of patients, especially
those who suffer from chronic conditions like depression, are turning to
their smartphones to supplement treatment they receive. The new app aims
to provide ongoing motivation in a simple and portable way. Moodivator
is designed to help complement the treatment patients receive by
allowing them to track their mood, set goals and establish routines that
can help support them in their daily life. The Moodivator app is free
and available to download for iPhones from the Apple App Store at https://itunes.apple.com/us/app/moodivator/id1103213442?ls=1&mt=8.

Treatment for depression often includes a number of approaches such as
talk therapy, medication, peer support and a personal wellness plan –
however, it may be challenging for some patients to adhere to their
treatment. Fortunately, advances in technology like Moodivator are
offering new ways to approach health management, encouraging them to
take a more active role in managing their condition. In fact, a 2014
survey found that 70% of patients being treated for a mental health
disorder say they want to use a mobile application to monitor their
mental health on a daily basis.

“As awareness of the magnitude and severity of depression continues to
mount, technology like the Moodivator app represents a new and exciting
frontier for helping people with depression. The option to set, track
and achieve personal goals in the Moodivator app ties in nicely with
cognitive behavioral therapy techniques that I use often with my
patients,” said Susan Kornstein, MD, professor of psychiatry at Virginia
Commonwealth University School of Medicine, who helped consult on the
app’s design. “The opportunity for patients to track and export their
mood and goal progress in easy-to-read charts is also very useful,
because the progress can then be shared with doctors to help inform care
decisions.”

Mobile apps offer the potential to help address key barriers to
accessing real-time support for depression. Designed to fit into
patients’ schedules and lifestyles, the Moodivator app uses a simple and
accessible interface with customizable features. Patients also receive
encouraging and inspirational messages in the app to help motivate them
as they work to manage their depression. This app includes a number of
simple features that leverage some best principles in managing
depression:

• Goal setting: Ability to create
  customizable, manageable goals with clear action steps to help
  patients achieve them, which can be made across one or more
  categories, including work, home and family or social activities.
  Goals can be adjusted over time and turned into helpful habits as part
  of an ongoing routine.
• Mood tracking: A simple scale lets
  patients track how they are feeling when it is convenient for them,
  whether multiple times a day or sporadically. Mood tracking is an
  important tool for improving patients’ emotional self-awareness.
  Tracking mood through a mobile app also offers the convenience of
  real-time reporting, which can make it easier to identify long-term
  patterns with their care team.
• Sharing results: Opportunity for patients
  to share their goal progress with their care team, showcasing their
  progress through clear charts.

The Moodivator app is not a treatment for depression. All patients
should work with their doctor to determine which course of treatment is
right for them, and even when patients start to feel better, they should
continue their therapy and work closely with their doctor until they
reach an agreement to conclude the treatment plan. This app includes
information about a prescription treatment option for depression.

About Pfizer Inc: Working together for a healthier world®

At Pfizer, we apply science and our global resources to bring therapies
to people that extend and significantly improve their lives. We strive
to set the standard for quality, safety and value in the discovery,
development and manufacture of health care products. Our global
portfolio includes medicines and vaccines as well as many of the world’s
best-known consumer health care products. Every day, Pfizer colleagues
work across developed and emerging markets to advance wellness,
prevention, treatments and cures that challenge the most feared diseases
of our time. Consistent with our responsibility as one of the world’s
premier innovative biopharmaceutical companies, we collaborate with
health care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world. For
more than 150 years, Pfizer has worked to make a difference for all who
rely on us. To learn more, please visit us at www.pfizer.com.

PP-PRQ-USA-0522

Downloadable Assets:

Contacts

Pfizer Inc
Media:
Rachel Hooper, 212-733-2105